Related Experiment Video
Updated: Apr 1, 2026

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma
Abstract:
We conducted a perspective study to investigate the role of ERCC1 (rs11615), ERCC2 (rs13181 and rs1799793), ERCC4 (rs1800067), and ERCC5 (rs17655) in NER pathway in the prognosis of osteosarcoma patients. In total, 146 osteosarcoma patients were recruited between 2008 and 2013. ERCC1 rs11615, ERCC2 rs13181 and rs1799793, ERCC4 rs1800067, and ERCC5 rs17655 gene polymorphisms were assessed by polymerase chain reaction-restriction fragment length polymorphism assay. By multivariate Cox proportional hazards models, we found that carriers of ERCC1 rs11615 TT genotype showed significantly favorable survival compared to wide-type CC genotype, and the adjusted OR (95%CI) was 0.24 (0.08-0.96). Moreover, we found that subjects with ERCC2 rs1799793 AA genotype were associated with decreased hazards of death in multivariate analysis (HR = 0.22, 95%CI = 0.12-0.93). In conclusion, our results suggest that ERCC1 rs11615 and ERCC2 rs1799793 may be useful genetic prognostic markers for osteosarcoma in a Chinese population.
Insights
Certain DNA repair gene variants, specifically ERCC1 rs11615 and ERCC2 rs1799793, show promise as prognostic markers for osteosarcoma patients. These findings may aid in predicting patient survival outcomes.
Area of Science:
- Genetics and Molecular Biology
- Oncology
- DNA Repair Mechanisms
Background:
- Osteosarcoma prognosis is influenced by various factors, including genetic predispositions.
- The Nucleotide Excision Repair (NER) pathway plays a crucial role in DNA damage repair and may impact cancer development and progression.
- Identifying genetic markers associated with NER could improve prognostic accuracy for osteosarcoma.
Purpose of the Study:
- To investigate the prognostic significance of specific gene polymorphisms within the NER pathway in osteosarcoma patients.
- To evaluate the association between ERCC1, ERCC2, ERCC4, and ERCC5 gene variants and patient survival outcomes.
Main Methods:
- A prospective study involving 146 osteosarcoma patients recruited between 2008 and 2013.
- Genotyping of ERCC1 (rs11615), ERCC2 (rs13181 and rs1799793), ERCC4 (rs1800067), and ERCC5 (rs17655) polymorphisms using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
- Multivariate Cox proportional hazards models were employed to analyze the association between genotypes and survival.
Main Results:
- Carriers of the ERCC1 rs11615 TT genotype exhibited significantly favorable survival compared to the wild-type CC genotype (adjusted OR = 0.24, 95% CI = 0.08-0.96).
- Individuals with the ERCC2 rs1799793 AA genotype were associated with decreased hazards of death in multivariate analysis (HR = 0.22, 95% CI = 0.12-0.93).
- No significant associations were found for ERCC2 rs13181, ERCC4 rs1800067, or ERCC5 rs17655 polymorphisms with osteosarcoma prognosis.
Conclusions:
- The ERCC1 rs11615 TT genotype and ERCC2 rs1799793 AA genotype may serve as valuable genetic prognostic markers for osteosarcoma.
- These findings suggest potential for incorporating specific NER pathway gene polymorphisms into clinical assessments for predicting osteosarcoma patient outcomes, particularly in Chinese populations.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
11:06Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
Overview of DNA Repair
Overview of DNA Repair
Chemically...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase